Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01832324 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Molecular Basis of Food Allergy

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years 10 months later Dec 2027 → Nov 2030
See other at-risk trials from Children's Hospital of Philadelphia

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 2027 to Nov 2030 Show 6 more changesShow less
    • Lead sponsor: Children's Hospital of Philadelphia to Children's Hospital of Philadelphia
    • Study completion pushed from Dec 2030 to Nov 2031
    • Eligibility criteria expanded, about 9 words
    • Site details revised
    • Collaborators: details revised at 1 of 2 entries
    • Publications: details revised at 2 of 2 entries
  2. Re-verified, no change to tracked fieldsv19
  3. Collaborators: 3 to 2v18
  4. Trial status: Recruiting to Enrolling by Invitation
    • Site details revised
    • Collaborators: 2 to 3
    v17
  5. Re-verified, no change to tracked fieldsv16
Show 14 earlier versionsHide 14 earlier versions
  1. Trial status: Active, Not Recruiting to Recruitingv15 Show 4 more changesShow less
    • Enrollment target: 1300 to 5300
    • Primary endpoints: 1 to 3
    • Site details revised
    • Eligibility criteria expanded, about 3 words
  2. Re-verified, no change to tracked fieldsv14
  3. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    • Collaborators: 3 to 2
    v13
  4. Collaborators: 2 to 3v12
  5. Primary completion date: Dec 2018 to Dec 2027
    • Study completion date: Dec 2019 to Dec 2030
    v11
  6. Re-verified, no change to tracked fieldsv10
  7. Site details revisedv9
  8. Re-verified, no change to tracked fieldsv8
  9. Eligibility criteria expanded, about 114 words
    • Study description expanded, about 74 words
    • Site contact updated
    • Collaborators: 1 to 2
    v7
  10. Re-verified, no change to tracked fieldsv6
  11. Enrollment target: 1000 to 1300v5
  12. Study completion date: Dec 2019v4
  13. Collaborators: 3 to 1v3
  14. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Study examines the molecular basis of food allergy. It explores the interaction between T cells, InKT cells, basophils and cytokines in the development of food allergy. The study also explores these factors in development of tolerance "outgrowing" food allergy. It will also explore the genetic factors that lead to the development of food allergy. The study examines all type of food allergy including IgE mediated reactions, Eosinophilic Esophagitis and Food Protein Induced Enterocolitis
Trial Details
NCT Number NCT01832324
Lead Sponsor Children's Hospital of Philadelphia
Collaborators: University of Pennsylvania, Children's Hospital Medical Center, Cincinnati
Conditions
(from sponsor)		 Food Allergy, Eosinophilic Esophagitis
Related terms Eosinophilic Esophagitis, Food Hypersensitivity
Enrollment 5,300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov